The pursuit of a universal influenza vaccine, which could protect against various strains of the virus without the need for annual vaccinations, has gained new momentum with reported $500 million federal funding plans. This funding is part of the Generation Gold Standard initiative by the U.S. Department of Health and Human Services and NIH, focusing on developing vaccines for both influenza and coronaviruses, responding to potential pandemic threats. The approach shifts from the former Project NextGen that emphasized COVID vaccine development. Experts express cautious optimism about the project's potential benefits.
Scientists have pursued a universal influenza vaccine for decades to protect against various strains, with recent plans for $500 million in funding marking significant progress.
The new initiative, Generation Gold Standard, aims to develop a universal vaccine platform but transitions from the previous $5 billion Project NextGen focused on COVID vaccines.
Collection
[
|
...
]